Paulo Pina

Paulo Pina

Auto-generated profile, based on publicly available information

Paulo Pina

Hasbro Children's Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2021 in JMIR Formative Research
Verified
Journal Article
Open access
SNSarah Nies
Sarah Nies
SPShae Patel
Shae Patel
MSMelissa Shafer
Melissa Shafer
LLLaura Longman
Laura Longman
ISIman Sharif
Iman Sharif
PPPaulo Pina
Paulo Pina
Background: In contrast to the current broad dissemination of telemedicine across medical specialties, previous research focused on the effectiveness of telemedicine in special populations and for behavioral health encounters, demonstrating that both physician and patient factors impact the efficacious use of telemedicine. Objective: We aim to evaluate physician perceptions of the appropriateness of telemedicine for patients attending the primary care practices of a federally qualified health center in New York City. Methods: We used an anonymous cross-sectional survey including closed- and open-ended questions. We used chi-square to test whether providers from certain specialties were more likely to state they would use telemedicine in the future. We used t tests to compare age between those who would versus would not use telemedicine. We then used logistic regression to test whether age and specialty were both correlated with the desire to use telemedicine in the future. We used thematic content analysis to describe the reasons providers felt they would not want to use telemedicine in the future and to describe the situations for which they felt telemedicine would be appropriate. Results: Of 272 health care providers who were sent the electronic survey, 157 (58%) responded within the 2-week survey time frame. The mean age of providers was 45 (range 28-75) years. Overall, 80% (126/157) stated they would use telemedicine in the future. Compared to the family medicine, internal medicine, behavioral health, dental, and obstetrics and gynecology specialties, providers from pediatrics, med-peds, subspecialties, and surgery (protelemedicine specialties) were more likely to believe telemedicine would be useful post pandemic (61/67 [91%] vs 65/90 [72%]; P<.001). Providers who reported they would use telemedicine in the future were younger (mean age 44, range 42-46 years vs mean age 50, range 46-55 years; P=.048). In the regression analysis, both protelemedicine specialties and age were significantly associated with odds of reporting they would use telemedicine in the future (prospecialties: odds ratio 5.2, 95% CI 1.7-16.2; younger age: odds ratio 1.05, 95% CI 1.01-1.08). Providers who did not want to use telemedicine in the future cited concerns about inadequate patient care, lack of physical patient interaction, technology issues, and lack of necessity. Providers who felt telemedicine would be useful cited the following situations: follow-up visits, medication refills, urgent care, patient convenience, and specific conditions such as behavioral health, dermatology visits, and chronic care management. Conclusions: The majority of health providers in this resource-limited setting in a federally qualified health center believed that telemedicine would be useful for providing care after the pandemic is over.

1 June 2021 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
NWNatasha Williams
Natasha Williams
HTHaleigh Tutrow
Haleigh Tutrow
PPPaulo Pina
Paulo Pina
HBHayley M. Belli
Hayley M. Belli
GOGbenga Ogedegbe
Gbenga Ogedegbe
ASAntoinette Schoenthaler
Antoinette Schoenthaler
Urban areas throughout the United States have been hardest hit by the COVID-19 pandemic, contributing to a major focus on increasing vaccine uptake. Despite ongoing discourse about vaccine hesitancy, vaccine access among underserved populations is underexplored. As of March 10, 2021, the New York City (NYC) Department of Health and Mental Hygiene reported that 1 250 370 residents had received at least 1 dose of a COVID-19 vaccine, including 19% of the non-Hispanic White population compared with a rate of only 9% among those who identified as African American/Black and Hispanic/Latinx.1 In this analysis, we review access to COVID-19 vaccination sites in Brooklyn, the most populated borough in NYC, to better understand disparities in vaccination.

8 October 2021 in AIDS Patient Care and STDs
Verified
Journal Article
Closed access
PPPaulo Pina
Paulo Pina
TTTamara Taggart
Tamara Taggart
MAMiguel Sanchez Acosta
Miguel Sanchez Acosta
IEIvie Eweka
Ivie Eweka
MMMiguel Muñoz-Laboy
Miguel Muñoz-Laboy
TATashuna Albritton
Tashuna Albritton
In the United States, Black and Latinx youth remain disproportionately affected by HIV. Oral antiretroviral pre-exposure prophylaxis (PrEP) is a proven effective HIV prevention strategy. PrEP is approved for use in people younger than the age of 18 years, but little is known about provider comfort and preparedness with prescribing it to adolescents. In this study, physicians provide their perspectives on the facilitators and barriers to PrEP access among adolescents. Focus groups ( n = 23) were conducted with pediatric and family practitioners practicing in an urban community hospital setting to assess PrEP awareness and receptivity to use among adolescents. Most providers were unfamiliar with clinical guidelines for PrEP use, especially in determining adolescent candidates for PrEP use, including appropriate dosing regimen and follow-up procedures. Overall, providers had low intent on prescribing PrEP, citing concerns about consent, medication adherence, and appropriateness of primary care providers in prescribing and managing adolescent PrEP use. Strategies that will address provider education and comfort in prescribing PrEP to adolescents are required to increase PrEP access and uptake among communities disproportionally affected by HIV.

9 August 2018 in Journal of Digestive Diseases
Verified
Journal Article
Closed access
PDF file
RCRuben J. Colman
Ruben J. Colman
NRNeal Bryan S. Rosario
Neal Bryan S. Rosario
ABAnalydia Gutierrez Bonilla
Analydia Gutierrez Bonilla
GAGabriela Benavidez Alvarez
Gabriela Benavidez Alvarez
JAJoel Benavidez Alvarez
Joel Benavidez Alvarez
DRDavid H. Rubin
David H. Rubin

27 August 2015 in Pediatric Obesity
Verified
Journal Article
Closed access
PDF file
RAR. Arun
R. Arun
PPP. Pina
P. Pina
DRD. Rubin
D. Rubin
DED. Erichsen
D. Erichsen

10 November 2021 in Journal of the Association of Nurses in AIDS Care
Verified
Journal Article
Closed access
SRSharanya Rao
Sharanya Rao
TATashuna Albritton
Tashuna Albritton
PPPaulo Pina
Paulo Pina
YLYilin Liang
Yilin Liang
TTTamara Taggart
Tamara Taggart
Pre-exposure prophylaxis (PrEP) stigma is an understudied barrier to PrEP uptake among Black and Latinx adolescents. U.S. Black and Latinx adolescents (13–17 years) completed an online survey or participated in focus groups/interviews. Associations between PrEP stigma, PrEP disclosure, and provider-initiated PrEP discussion preferences were examined using logistic-regression models. Qualitative data provided further context to quantitative findings. The survey sample included 208 adolescents (53% female; 58% Latinx; M = 15 years), with 98% endorsing PrEP stigma. The qualitative sample included 26 adolescents (54% female; 34% Latinx; M = 15 years). PrEP stigma was associated with lower odds of PrEP disclosure to parents/guardians, and preference for health care providers to initiate PrEP-related discussions only with patients the provider judged to be at high risk for HIV. Qualitative data supported quantitative results: Adolescents endorsed multiple negative stereotypes about PrEP users. Mitigating PrEP stigma among Black and Latinx adolescents is an important step in overcoming challenges related to PrEP uptake.